Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant
Status:
Completed
Trial end date:
2017-12-15
Target enrollment:
Participant gender:
Summary
The main purpose of this trial is to assess the efficacy and safety of sitagliptin in
enhancing engraftment following umbilical cord blood transplantation (recovery of blood
counts after transplant).